Vaishnavi G. Gole, S. L. Patwekar, Ankush Doiphode, Ashwini Rode, Suleman Shaikh
Vaishnavi G. Gole*, S. L. Patwekar, Ankush Doiphode, Ashwini Rode, Suleman Shaikh
Department of Pharmaceutics, School of Pharmacy, SRTMU, Nanded. (431606).
Volume - 12,
Issue - 3,
Year - 2022
The solid porous particles have a nanocavity structure in which drugs are encapsulated known as nanosponges. There are five types of nanosponges. Nanosponges size varies from 1um and less than 1 um. Nanosponges are stable at high temperatures. It has high drug loading capacity. Nanosponges formulation overcomes stability, delayed-release activity, and solubility-related problems. Nanosponges can deliver the drug through oral, parenteral, and topical routes. The current review focuses on nanosponges in drug delivery systems including their synthesis, characterization, and diverse applications.
Cite this article:
Vaishnavi G. Gole, S. L. Patwekar, Ankush Doiphode, Ashwini Rode, Suleman Shaikh. A Overview on Nanosponges. Asian Journal of Research in Pharmaceutical Sciences. Sci. 2022; 12(3):210-2. doi: 10.52711/2231-5659.2022.00037
Vaishnavi G. Gole, S. L. Patwekar, Ankush Doiphode, Ashwini Rode, Suleman Shaikh. A Overview on Nanosponges. Asian Journal of Research in Pharmaceutical Sciences. Sci. 2022; 12(3):210-2. doi: 10.52711/2231-5659.2022.00037 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2022-12-3-9
1. Himangshu Bhowmik, D.Nagasamy Venkatesh,Anuttam Kuila, KammariHarish Kumar. Nanosponges: A Review. International journal of applied pharmaceutics. 2018 May 24; 10(4):1-4.
2. Bolmal UB, Manvi FV, Rajkumar K, Palla SS, Paladugu A, Reddy KR. Recent advances in nanosponges as drug delivery system. International Journal of Pharmaceutical Sciences and Nanotechnology.2013;6:1934-44.
3. Trotta F, Zanetti M, Cavalli R. Cyclodextrin-based nanosponges as drug carriers. Beilstein J Org Chem. 2012;8:2091–9.
4. Farooq SA, Saini V. Application of novel drug delivery system in the pharmacotherapy of hyperlipidemia. J Chem Pharm Sci. 2013;6:138-46.
5. Shrishail M Ghurghure, Mahewash Sana Asadulla Pathan, Priyanka Ramesh Surwase. Nanosponges: A novel approach for targeted drug delivery system. International Journal of Chemistry Studies. 2018 Nov ;2(6):1-8.
6. Bezawada S, Charanjitha, Reddy MV, Naveena, Gupta RM. Nanosponges: A Concise Review for Emerging Trends. Int J Pharm Res Biomed Ana. 2014; 3:1.
7. Targe BM, Patil MP, Jahagirdar Baliram D. Nanosponges : An emerging Drug Delivery System. Int J of Insti Pharm and Life Sci. 2015; 5(6):160- 173.
8. Kurhe A, Kendre P, Pande V. Scaffold Based Drug Delivery System: A Special Emphasis on Nanosponges. Int J Pharma Drug Ana. 2015; 4(3):98-104.
9. Patel EK, Oswal RJ. Nanosponge and Microsponges: A Novel Drug Delivery System. International Journal of Research in Pharmacy and Chemistry.2012.
10. Subramanian S, Sinireddy A, Krishnamoorthy K, Rajappan M. A Novel Class of Drug Delivery System Review. J Pharm Sci. 2012; 15(1):103- 111.
11. Jyoti P, Tulsi B, Popin K, Chetna B. An Innovative Advancement for Targeted Drug Delivery: Nanosponges, IndoGlobal J Pharm Sci. 2016; 6(2):59-64.
12. Srinivas P, Sreeja. K. Formulation and Evaluation of Voriconazole Loaded Nanosponges for Oral and Topical Delivery. Int J Drug Dev Res. 2013; 5(1):55-68.
13. Dora CP, Trotta F, Kushwah V, Devasari N, Singh C, Suresh S, Jain S. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability, Carbohydrate Polymers. 2015.
14. Sharma R, Pathak K. Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Tech. 2011; 16(4):367-376.
15. Swaminathan S, Vavia PR, Trotta F, Torne S. Formulation of betacyclodextrin based nanosponges of itraconazole. J Inclusion Phenomena and Macrocyclic Chemistry. 2017; 57:89-94.
16. Renu kaivalya, D. Prasad, Dr. M. Sudhakar, Dr. S.B.Bhanja and M. Tejaswi. A review on nanosponges. 2020 Jan;11(01 C): 36878-36884.
17. Rosalba M, Roberta C, Piergioorgio P, Roberto F, Leigh E and Chiara D. (2011). Antitumor activity of nanosponges –encapsulated camptotechin in human prostate tumors. 71(8), 4431-4431.
18. JAnsari KA, Vavia PR, Trotta F and Cavalli R. (2011). Cyclodextrin –based nanosponges for delivery of resveratrol: in vitro characterization, stability, and cytotoxicity and permeation study. AAPS Pharm Sci Tech. 12(1), 279-286.
19. D.Lemboa, S Swaminathan and M. Donalisioa.Encapsulation of acyclovir in new carboxylated cyclodextrin based nanosponges improves the agent antiviral efficacy. International Journal of Pharmaceutics. 2013; 443(1-2), 262-272.
20. Guo L, Gao G, Liu X and Liu F. Preparation and characterization of Tio2 nanosponges. Materials Chemistry and Physics.2008; 111(2-3), 322- 325.
21. Madhuri Shringirishi, Sunil Kumar Prajapati, Alok Mahor, Shashi Alok , Poonam Yadav, Amita Verma. Nanosponges: a potential nanocarrier for novel drug delivery a review. Asian Pac J Trop Dis. 2014; 4(Suppl 2): S519-S526.
22. Subramanian S, Singireddy A, Krishnamoorthy K,Rajappan M. Nanosponges: a novel class of drug delivery system-review. J Pharm Sci.2012; 15(1): 103-111.
23. Singh R, Bharti N, Madan J, Hiremath SN. Characterization of cyclodextrin inclusion complexes-a review. J Pharm Sci Technol. 2010; 2(3): 171- 183.
24. A. R. Thakre, Y. N. Gholse, R. H. Kasliwal. Nanosponges: A NovelApproach of Drug Delivery System. Journal of Medical Pharmaceutical And Allied Sciences. 2016 June ;(2320 – 7418): 85.
25. Sharma R, Roderick B and Pathak K. Evaluation of kinetics and mechanism of drug release from Econazole nitrate Nanosponges loaded carbopol Hydrogel. Indian J of Pharma Edu andresearch.2011; 45(1):25-31.